SCHEMBL3405528

SCHEMBL3405528

CCCCC1(N(C)C)CCN(CCN(C)Cc2ccc3cc[nH]c3c2)CC1

nearest known ligand 0.41

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 8/20 0.41
CYP2D6 P10635 1/20 0.35
SLC6A2 P23975 1/20 0.35
SLC6A4 P31645 1/20 0.35
SLC6A3 Q01959 1/20 0.35
KCNH2 Q12809 1/20 0.35
FFAR2 O15552 3/20 0.33
OPRM1 P35372 2/20 0.33
OPRL1 P41146 2/20 0.33
ACHE P22303 1/20 0.33
HTR4 Q13639 1/20 0.33
BACE1 P56817 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3407864 0.93 KCNH2 (0.41) SIGMAR1CYP2D6SLC6A2SLC6A4SLC6A3
SCHEMBL3410197 0.79 ALDH1A1 (0.42) CYP2D6SLC6A2SLC6A4SLC6A3OPRM1
SCHEMBL3409919 0.79 BCHE (0.47) SIGMAR1OPRM1OPRL1ACHE
SCHEMBL3410720 0.79 SIGMAR1 (0.41) SIGMAR1OPRM1OPRL1
SCHEMBL3407006 0.78 SIGMAR1 (0.41) SIGMAR1FFAR2OPRM1OPRL1
SCHEMBL3409432 0.75 SIGMAR1 (0.43) SIGMAR1SLC6A2SLC6A4SLC6A3KCNH2
SCHEMBL3405023 0.73 BCHE (0.48) SIGMAR1CYP2D6OPRM1OPRL1ACHE
SCHEMBL3407016 0.73 HTR1A (0.49) SIGMAR1SLC6A2SLC6A4SLC6A3
SCHEMBL3434090 0.71 SIGMAR1 (0.41) SIGMAR1CYP2D6SLC6A2SLC6A4SLC6A3
SCHEMBL4103306 0.69 SIGMAR1 (0.43) SIGMAR1CYP2D6SLC6A2SLC6A4SLC6A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9206156-B2 Substituted indole derivatives Grünenthal GmbH (DE) 2015-12-08 US claimed
EP-2254883-B1 SUBSTITUTED INDOLE DERIVATIVES GRUENENTHAL GMBH (DE) 2014-11-26 EP claimed
US-20130116283-A1 Substituted indole derivatives Grünenthal GmbH (DE) 2013-05-09 US claimed
EP-2254883-A1 SUBSTITUTED INDOLE DERIVATIVES Grünenthal GmbH (DE) 2010-12-01 EP claimed
WO-2009103552-A1 SUBSTITUTED INDOLE DERIVATIVES Grünenthal GmbH (DE) 2009-08-27 WO claimed
US-20090215828-A1 Substituted indole derivatives GRUNENTHAL GMBH (DE) 2009-08-27 US claimed
US-9206156-B2 Substituted indole derivatives Grünenthal GmbH (DE) 2015-12-08 US disclosed
EP-2254883-B1 SUBSTITUTED INDOLE DERIVATIVES GRUENENTHAL GMBH (DE) 2014-11-26 EP disclosed
US-20130116283-A1 Substituted indole derivatives Grünenthal GmbH (DE) 2013-05-09 US disclosed
EP-2254883-A1 SUBSTITUTED INDOLE DERIVATIVES Grünenthal GmbH (DE) 2010-12-01 EP disclosed
WO-2009103552-A1 SUBSTITUTED INDOLE DERIVATIVES Grünenthal GmbH (DE) 2009-08-27 WO disclosed
US-20090215828-A1 Substituted indole derivatives GRUNENTHAL GMBH (DE) 2009-08-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090215828-A1 Substituted indole derivatives IDO1, IDO2, TPH1 SIGMAR1 235/4885CYP2D6 57/4885SLC6A2 198/4885
US-20130116283-A1 Substituted indole derivatives IDO1, IDO2, TPH1 SIGMAR1 235/4885CYP2D6 57/4885SLC6A2 198/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.